Clinical‑grade stem cell and gene editing services to accelerate your translational pathway
❯ For Cell Therapy Developers
Quality Stem Cells for High-Impact Research
❯ For Stem Cell Researchers
Supporting your preclinical research goals from bench to bedside
❯ For Diagnostic Developers
Human Tissue Samples
Genomic Services
From discovery to decision, human data that de-risks your drug pipeline
❯ For Preclinical Drug Developers
One global partner for clinical logistics, processing, and data you can trust
❯ For Clinical Drug Developers
Cells and products for stem cell research and 3D cell culture
❯ All products
❯ Featured products
Our product catalog covers the territories of REPROCELL USA (Americas), REPROCELL Europe (EMEA), and Bioserve India.
Stem Cell Reagents
Cells
Stem Cell Products
3D Cell Culture
Labware
Upcoming Conferences
❯ Other events
Latest on our Blog
❯ More on the blog
REPROCELL Brands
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)
Contact REPROCELL Global
Connect with our expert scientists and sales teams worldwide. We will figure out who's best to reply to you.
❯ Contact us other ways
US Sales Inquiries
EU Sales Inquiries
India Sales Inquiries